Sign In
Get Clay Free →

Suggestions

    Thomas Wagner

    Chief Executive Officer at Orbis Health Solutions, LLC

    Thomas Edwards Wagner, Ph.D. is the Chief Executive Officer at Orbis Health Solutions, LLC, a position he has held since 2009.1 He is a distinguished scientist and researcher with an extensive background in biochemistry, molecular biology, and cancer research.

    Dr. Wagner's career spans over five decades, during which he has held numerous academic and research positions:

    • Professor of Biological Sciences at Clemson University (2003-2010)1
    • Distinguished Professor of Molecular Medicine at Clemson University (1998-2003)1
    • Director of Oncology Research Institute at Greenville Hospital System (1998-2009)1
    • Distinguished Professor of Molecular & Cellular Biology at Ohio University (1993-1998)1
    • Professor of Biochemistry at Ohio University (1975-1993)1

    He also founded and directed the Edison Biotechnology Institute at Ohio University from 1984 to 1990.1

    Dr. Wagner's educational background includes:

    • Ph.D. in Biochemistry from Northwestern University1
    • Bachelor of Arts in Chemistry and Biology (magna cum laude) from Princeton University1

    In recent years, Dr. Wagner has focused on developing innovative cancer treatments. He is dedicated to revolutionizing cancer therapy by creating a personalized cancer vaccine that minimizes debilitating side effects often associated with traditional approaches.2 His company, Orbis Health Solutions, has developed a tumor lysate particle only (TLPO) vaccine that harnesses the power of the immune system to fight cancer.2

    This TLPO vaccine has shown promising results in Phase 2 clinical trials for advanced melanoma and is now entering Phase 3 trials.2 Dr. Wagner's goal is to create a cancer treatment that avoids harmful side effects by leveraging the body's immune system, potentially transforming the landscape of cancer therapy.2

    Highlights

    Jan 24 · contactout.com
    Thomas Wagner Email & Phone Number | Orbis Health Solutions, LLC
    Jan 24 · abcnews.go.com
    Cancer vaccine with minimal side effects nearing Phase 3 clinical trials
    Cancer vaccine with minimal side effects nearing Phase 3 clinical trials
    Jan 22 · medtigo.com
    Cancer Vaccine Enters Phase 3 Trials After FDA Approval | medtigo
    ORBIS ANNOUNCES LEADERSHIP CHANGES

    Related Questions

    What are Thomas Wagner's main achievements at Orbis Health Solutions?
    How did Thomas Wagner transition from academia to leadership roles?
    What is the focus of Orbis Health Solutions under Thomas Wagner's leadership?
    How has Thomas Wagner's career impacted the biomedical industry?
    What are some notable projects Thomas Wagner has led at Orbis Health Solutions?
    T
    Add to my network

    Location

    Greenville, South Carolina